Nasdaq 100 slightly fell -0.05% (-5.38 pts), closed at 10786 points, fell 6 days in a row, hit a YTD low.
Among the 150 largest-cap stocks, 63 (42%) closed higher. 45% of all Nasdaq stocks ended higher.
In terms of sectors, 4 sectors closed up, 8 sectors closed down, ranging from -3.1% to 1%. 4 sectors outperformed the market, the market internal was more negative. The market was down -0.1%; Consumer Defensive was up 1%, the best performer, reflecting a decreasing risk appetite; Utilities was down -3.1%, the worst performer.
● BeiGene (BGNE) largely rebounded 20.4% (+$25.61) after a 5-day losing streak, closed at $151.12, the best % gain in nearly 7 months, crossed above MA20 ($142.54). The best performer with a huge increase in volume.
360miq.com/stockinfo?code=BGNE
● Moderna (MRNA) largely rebounded 8.3% (+$10), closed at $130.725, the best % gain in more than 2 months, crossed above MA20 ($124.85). The largest increase in volume.
360miq.com/stockinfo?code=MRNA
● T. Rowe Price Group (TROW) plummeted -5.2% (-$5.33), closed at $98.05, fell 6 days in a row, hit a YTD low. The worst performer with a huge increase in volume.
360miq.com/stockinfo?code=TROW
360miq.com/market?data=NASDAQ#tab-3
